GD2-SADA:177Lu-DOTA Complex

· Y-mAbs Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GD2-SADA:177Lu-DOTA Complex, covering 2024-10-02 to 2026-06-18. Get the full timeline:

Most recent: Clinical Trial Results: GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2 [Phase 1]